{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:31:56Z","timestamp":1790818316524,"version":"4.1.0"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T00:00:00Z","timestamp":1335139200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035670","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T21:36:21Z","timestamp":1335216981000},"page":"e35670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein\/Vaccine Candidate against Visceral Leishmaniasis"],"prefix":"10.1371","volume":"7","author":[{"given":"Pramod Kumar","family":"Kushawaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Dev Pati","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives.","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis.","volume":"354","author":"BL Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"ref3","first-page":"2","article-title":"Advances in battle against leishmaniasis.","volume":"57","year":"1998","journal-title":"TDR News"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe.","volume":"97","author":"P Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref5","first-page":"407","article-title":"Diagnosis & management of leishmania\/HIV co-infection.","volume":"121","author":"PK Sinha","year":"2005","journal-title":"Indian J Med Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0035-9203(88)90017-X","article-title":"Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro.","volume":"82","author":"SL Croft","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.","volume":"157","author":"HW Murray","year":"1988","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.47.5.1529-1535.2003","article-title":"The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis.","volume":"47","author":"KC Carter","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.","volume":"47","author":"FJ Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis.","volume":"6","author":"S Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis.","volume":"89","author":"F Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","article-title":"Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.","volume":"173","author":"O Bacellar","year":"1996","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI113969","article-title":"Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.","volume":"83","author":"EM Carvalho","year":"1989","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/IAI.33.2.498-500.1981","article-title":"Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.","volume":"33","author":"EM Carvalho","year":"1981","journal-title":"Infect Immun"},{"key":"ref16","first-page":"58","article-title":"Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.","volume":"56","author":"B Galvao-Castro","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections.","volume":"92","author":"HW Ghalib","year":"1993","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0090-1229(90)90038-R","article-title":"Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.","volume":"57","author":"K Zwingenberger","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.","volume":"165","author":"EM Carvalho","year":"1992","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response.","volume":"356","author":"DC Tang","year":"1992","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein.","volume":"259","author":"JB Ulmer","year":"1993","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.67.9.5664-5667.1993","article-title":"Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.","volume":"67","author":"GJ Cox","year":"1993","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo.","volume":"247","author":"JA Wolff","year":"1990","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines.","volume":"15","author":"JJ Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.","volume":"186","author":"S Gurunathan","year":"1997","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.","volume":"9","author":"PS Walker","year":"1998","journal-title":"Hum Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.","volume":"69","author":"A Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1086\/430348","article-title":"A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis.","volume":"191","author":"P Tewary","year":"2005","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.","volume":"174","author":"R Basu","year":"2005","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes.","volume":"7","author":"SK Gupta","year":"2007","journal-title":"Proteomics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"31438","DOI":"10.1074\/jbc.M503377200","article-title":"Interactions among yeast protein-disulfide isomerase proteins and endoplasmic reticulum chaperone proteins influence their activities.","volume":"280","author":"T Kimura","year":"2005","journal-title":"J Biol Chem"},{"key":"ref32","first-page":"294","article-title":"[Cloning and sequence analysis of the ribosomal DNA ITS gene of Leishmania donovani isolates from hill foci of China].","volume":"22","author":"Y Tian","year":"2004","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/IAI.55.10.2409-2415.1987","article-title":"Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans.","volume":"55","author":"RL Gregory","year":"1987","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-5699(97)01229-2","article-title":"Mucosal immunology and the eye.","volume":"19","author":"M Zierhut","year":"1998","journal-title":"Immunol Today"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.70.7.3576-3585.2002","article-title":"Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor.","volume":"70","author":"Y Ben Achour","year":"2002","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.","volume":"140","author":"R Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.","volume":"96","author":"A Dube","year":"2005","journal-title":"Parasitol Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent.","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.","volume":"76","author":"H Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.","volume":"24","author":"R Garg","year":"2006","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.","volume":"25","author":"S Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.","volume":"141","author":"AH Ding","year":"1988","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-Type immunoprotective response against experimental visceral leishmaniasis.","volume":"183","author":"M Samant","year":"2009","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming.","volume":"90","author":"RA Seder","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.179.2.447","article-title":"Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.","volume":"179","author":"SL Reiner","year":"1994","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.","volume":"26","author":"AP Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice.","volume":"24","author":"MR Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals.","volume":"26","author":"N Khoshgoo","year":"2008","journal-title":"Vaccine"},{"key":"ref50","article-title":"Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.","author":"S Kumari","year":"2008","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0014-5793(02)02911-3","article-title":"Protein disulfide isomerase of Toxoplasma gondii is targeted by mucosal IgA antibodies in humans.","volume":"522","author":"B Meek","year":"2002","journal-title":"FEBS Lett"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.","volume":"201","author":"SA Miles","year":"2005","journal-title":"J Exp Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijpara.2007.08.010","article-title":"Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.","volume":"38","author":"N Wanasen","year":"2008","journal-title":"Int J Parasitol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1074\/jbc.M210322200","article-title":"An atypical protein disulfide isomerase from the protozoan parasite Leishmania containing a single thioredoxin-like domain.","volume":"278","author":"A Padilla","year":"2003","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/prca.200780017","article-title":"Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis.","volume":"3","author":"S Kumari","year":"2008","journal-title":"Proteomics - Clinical Application"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa.","volume":"26","author":"S Kumari","year":"2008","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/eji.1830211216","article-title":"Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages.","volume":"21","author":"FY Liew","year":"1991","journal-title":"Eur J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major.","volume":"24","author":"J Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.147.10.3575","article-title":"Human T cell responses to gp63, a surface antigen of Leishmania.","volume":"147","author":"DM Russo","year":"1991","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4049\/jimmunol.146.2.742","article-title":"Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses.","volume":"146","author":"JM Burns Jr","year":"1991","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.143.1.266","article-title":"Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H\/HeN mice to infection with Leishmania major.","volume":"143","author":"M Belosevic","year":"1989","journal-title":"J Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.147.5.1653","article-title":"Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.","volume":"147","author":"BJ Holaday","year":"1991","journal-title":"J Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function.","volume":"15","author":"J MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.","volume":"166","author":"PC Melby","year":"2001","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2307\/3284319","article-title":"Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes.","volume":"83","author":"N Ali","year":"1997","journal-title":"J Parasitol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice.","volume":"70","author":"F Afrin","year":"2002","journal-title":"Infect Immun"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.","volume":"22","author":"RX Armijos","year":"2004","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1098\/rstb.1984.0111","article-title":"Mechanisms of acquired immunity in leishmaniasis.","volume":"307","author":"JG Howard","year":"1984","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref69","first-page":"318","article-title":"Serological investigations on Indian kala-azar.","volume":"40","author":"AC Ghose","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0769-2625(87)80036-3","article-title":"Identification of T-cell-reactive antigens that protect BALB\/c mice against Leishmania major.","volume":"138","author":"P Scott","year":"1987","journal-title":"Ann Inst Pasteur Immunol"},{"key":"ref71","first-page":"153","article-title":"Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.","author":"PA Bretscher","year":"1997","journal-title":"Behring Inst Mitt"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.","volume":"116","author":"K Kemp","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"ref73","first-page":"173","article-title":"Cytokine-producing T cell subsets in human leishmaniasis.","volume":"48","author":"K Kemp","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.","volume":"61","author":"M Kemp","year":"1993","journal-title":"Infect Immun"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.","volume":"145","author":"FY Liew","year":"1990","journal-title":"J Immunol"},{"key":"ref76","first-page":"556","article-title":"Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine.","volume":"71","author":"FY Liew","year":"1990","journal-title":"Immunology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.4049\/jimmunol.170.10.5152","article-title":"The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.","volume":"170","author":"N Noben-Trauth","year":"2003","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar: marked elevation of both interleukin-10 and interferon-g.","volume":"91","author":"CL Karp","year":"1993","journal-title":"J Clin Invest"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.","volume":"182","author":"HW Murray","year":"2000","journal-title":"J Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-3024.1992.tb00005.x","article-title":"Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.","volume":"14","author":"V Rodrigues Junior","year":"1992","journal-title":"Parasite Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T20:13:47Z","timestamp":1713903227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035670"}},"subtitle":[],"editor":[{"given":"Luciana C. C.","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,23]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,23]]}}}